Llido, Ailyn M.
HRN: 21-52-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2022
CEFUROXIME 500MG (TAB)
07/03/2022
07/10/2022
PO
500mg
Q12H
S/p LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes